Context Therapeutics Inc. (CNTX)
NASDAQ: CNTX · Real-Time Price · USD
2.620
+0.170 (6.94%)
At close: Mar 31, 2026, 4:00 PM EDT
2.650
+0.030 (1.15%)
Pre-market: Apr 1, 2026, 7:20 AM EDT
Context Therapeutics Market Cap
Context Therapeutics has a market cap or net worth of $240.72 million as of April 1, 2026. Its market cap has increased by 218.90% in one year.
Market Cap
240.72M
Enterprise Value
174.84M
1-Year Change
218.90%
Ranking
Category
Stock Price
$2.62
Market Cap Chart
Since the IPO on October 20, 2021, Context Therapeutics's market cap has increased from $51.03M to $240.72M, an increase of 371.75%. That is a compound annual growth rate of 41.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 31, 2026 | 240.72M | 78.23% |
| Dec 31, 2025 | 135.06M | 43.39% |
| Dec 31, 2024 | 94.19M | 422.07% |
| Dec 29, 2023 | 18.04M | 73.39% |
| Dec 30, 2022 | 10.41M | -75.50% |
| Dec 31, 2021 | 42.46M | -16.78% |
| Oct 20, 2021 | 51.03M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Orchestra BioMed Holdings | 238.18M |
| Silence Therapeutics | 235.23M |
| Cellectis | 233.21M |
| Voyager Therapeutics | 230.65M |
| C4 Therapeutics | 229.31M |
| OmniAb | 225.86M |
| Sol-Gel Technologies | 224.06M |
| Alector | 222.93M |